Total Payments
$1.5M
2024 Payments
$237,406
Companies
80
Transactions
3,395
Medicare Patients
1,823
Medicare Billing
$224,636
Payment Breakdown by Category
Other$1.2M (79.9%)
Travel$127,633 (8.7%)
Consulting$95,934 (6.6%)
Food & Beverage$60,978 (4.2%)
Research$7,161 (0.5%)
Education$1,864 (0.1%)
Gifts$118.80 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1.1M | 670 | 73.8% |
| Travel and Lodging | $127,633 | 443 | 8.7% |
| Consulting Fee | $95,934 | 56 | 6.6% |
| Food and Beverage | $60,978 | 2,123 | 4.2% |
| Honoraria | $60,064 | 25 | 4.1% |
| Compensation for serving as faculty or as a speaker for a medical education program | $29,875 | 10 | 2.0% |
| Unspecified | $7,161 | 9 | 0.5% |
| Education | $1,864 | 56 | 0.1% |
| Gift | $118.80 | 2 | 0.0% |
| Long term medical supply or device loan | $49.95 | 1 | 0.0% |
Payments by Type
General
$1.5M
3,386 transactions
Research
$7,161
9 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $429,207 | 748 | $0 (2024) |
| Corcept Therapeutics | $290,678 | 340 | $0 (2024) |
| Lilly USA, LLC | $252,298 | 566 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $128,553 | 179 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $81,388 | 175 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $64,102 | 148 | $0 (2024) |
| Dexcom, Inc. | $57,047 | 120 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $36,719 | 57 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $34,848 | 89 | $0 (2019) |
| ABBVIE INC. | $19,311 | 87 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $237,406 | 421 | Corcept Therapeutics ($104,017) |
| 2023 | $116,220 | 342 | Lilly USA, LLC ($47,544) |
| 2022 | $198,500 | 442 | Novo Nordisk Inc ($80,418) |
| 2021 | $124,645 | 372 | Novo Nordisk Inc ($66,184) |
| 2020 | $147,261 | 309 | Corcept Therapeutics ($56,331) |
| 2019 | $187,755 | 450 | Novo Nordisk Inc ($53,886) |
| 2018 | $199,140 | 508 | Novo Nordisk Inc ($66,117) |
| 2017 | $252,966 | 551 | AstraZeneca Pharmaceuticals LP ($57,907) |
All Payment Transactions
3,395 individual payment records from CMS Open Payments — Page 1 of 136
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | BETA BIONICS, INC. | iLet Bionic Pancreas (Device), iLet Bionic Pancreas, iLet Bionic Pancreas | Food and Beverage | In-kind items and services | $126.36 | General |
| Category: Automated insulin delivery system | ||||||
| 12/20/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $21.03 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 12/20/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $12.61 | General |
| Category: Cardiology | ||||||
| 12/18/2024 | Corcept Therapeutics | Korlym (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,900.00 | General |
| Category: Endocrinology | ||||||
| 12/18/2024 | Corcept Therapeutics | Korlym (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,400.00 | General |
| Category: Endocrinology | ||||||
| 12/18/2024 | Corcept Therapeutics | Korlym (Drug) | Travel and Lodging | In-kind items and services | $573.60 | General |
| Category: Endocrinology | ||||||
| 12/18/2024 | Corcept Therapeutics | Korlym (Drug) | Travel and Lodging | In-kind items and services | $540.95 | General |
| Category: Endocrinology | ||||||
| 12/18/2024 | Corcept Therapeutics | Korlym (Drug) | Travel and Lodging | In-kind items and services | $316.67 | General |
| Category: Endocrinology | ||||||
| 12/18/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $101.24 | General |
| Category: Endocrinology | ||||||
| 12/18/2024 | Corcept Therapeutics | Korlym (Drug) | Travel and Lodging | Cash or cash equivalent | $99.16 | General |
| Category: Endocrinology | ||||||
| 12/18/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: Diabetes Care | ||||||
| 12/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: DIABETES | ||||||
| 12/13/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: Endocrinology | ||||||
| 12/12/2024 | Corcept Therapeutics | Korlym (Drug) | Travel and Lodging | In-kind items and services | $1,757.50 | General |
| Category: Endocrinology | ||||||
| 12/12/2024 | Corcept Therapeutics | Korlym (Drug) | Travel and Lodging | In-kind items and services | $517.94 | General |
| Category: Endocrinology | ||||||
| 12/12/2024 | Corcept Therapeutics | Korlym (Drug) | Travel and Lodging | In-kind items and services | $244.12 | General |
| Category: Endocrinology | ||||||
| 12/12/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Endocrinology | ||||||
| 12/12/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $25.73 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/11/2024 | Corcept Therapeutics | Korlym (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,900.00 | General |
| Category: Endocrinology | ||||||
| 12/10/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $43.88 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 12/09/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $23.43 | General |
| Category: Endocrinology | ||||||
| 12/09/2024 | RECORDATI_RARE_DISEASES_INC. | ISTURISA (Drug) | Food and Beverage | In-kind items and services | $20.60 | General |
| Category: ENDOCRINE AGENT | ||||||
| 12/09/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $19.27 | General |
| Category: Endocrinology | ||||||
| 12/06/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $19.81 | General |
| Category: DIABETES | ||||||
| 12/05/2024 | Corcept Therapeutics | Korlym (Drug) | Travel and Lodging | In-kind items and services | $635.96 | General |
| Category: Endocrinology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| LCI699-RECAG-PASS-0572 | RECORDATI_RARE_DISEASES_INC. | $7,161 | 9 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 490 | 809 | $136,680 | $59,076 |
| 2022 | 4 | 410 | 720 | $122,934 | $55,074 |
| 2021 | 5 | 484 | 830 | $140,550 | $63,864 |
| 2020 | 4 | 439 | 686 | $117,564 | $46,622 |
Total Patients
1,823
Total Services
3,045
Medicare Billing
$224,636
Procedure Codes
19
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 336 | 606 | $109,080 | $49,668 | 45.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 41 | 41 | $11,070 | $4,010 | 36.2% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 76 | 122 | $11,468 | $3,007 | 26.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 12 | 14 | $3,360 | $1,763 | 52.5% |
| 95249 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin | Office | 2023 | 12 | 12 | $1,380 | $494.31 | 35.8% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 13 | 14 | $322.00 | $133.28 | 41.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 309 | 572 | $101,189 | $46,803 | 46.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 33 | 33 | $8,826 | $3,773 | 42.7% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 56 | 100 | $9,400 | $2,517 | 26.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 12 | 15 | $3,519 | $1,981 | 56.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 333 | 635 | $109,855 | $52,588 | 47.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 49 | 49 | $12,936 | $5,348 | 41.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 22 | 27 | $6,237 | $2,786 | 44.7% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Office | 2021 | 64 | 103 | $9,682 | $2,522 | 26.1% |
| 95249 | Continuous monitoring of glucose in tissue fluid using sensor under skin | Office | 2021 | 16 | 16 | $1,840 | $619.95 | 33.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 331 | 552 | $95,496 | $38,522 | 40.3% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 55 | 55 | $14,558 | $5,903 | 40.5% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Office | 2020 | 39 | 65 | $6,110 | $1,601 | 26.2% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 14 | 14 | $1,400 | $595.89 | 42.6% |
About Dr. Bradley Eilerman, MD
Dr. Bradley Eilerman, MD is a Endocrinology, Diabetes & Metabolism healthcare provider based in Florence, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1841389822.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bradley Eilerman, MD has received a total of $1.5M in payments from pharmaceutical and medical device companies, with $237,406 received in 2024. These payments were reported across 3,395 transactions from 80 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($1.1M).
As a Medicare-enrolled provider, Eilerman has provided services to 1,823 Medicare beneficiaries, totaling 3,045 services with total Medicare billing of $224,636. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism|Pediatrics|Pediatrics
- Location Florence, KY
- Active Since 10/11/2006
- Last Updated 04/30/2024
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1841389822
Products in Payments
- Korlym (Drug) $290,678
- Saxenda (Drug) $161,575
- FARXIGA (Drug) $119,103
- MOUNJARO (Drug) $94,561
- JARDIANCE (Drug) $83,399
- ZEPBOUND (Drug) $74,795
- Wegovy (Drug) $69,170
- Ozempic (Drug) $68,989
- TRULICITY (Drug) $47,280
- TOUJEO (Drug) $39,809
- Kerendia (Drug) $36,719
- Victoza (Drug) $34,836
- INVOKANA (Drug) $34,786
- DEXCOM G7 GSS (161) (Medical Supply) $25,419
- RYBELSUS (Drug) $25,183
- Tresiba (Drug) $22,722
- SOLIQUA (Drug) $16,479
- Rybelsus (Drug) $16,173
- Synthroid (Drug) $10,959
- Dexcom G6 Transmitter (Medical Supply) $10,503
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Florence
Dr. Peter Butler, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $216,269
Endocrinology, Diabetes & Metabolism $216,269
Gerald Miele, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $153,543
Endocrinology, Diabetes & Metabolism $153,543
Dr. Bethany Jackson, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $127,544
Endocrinology, Diabetes & Metabolism $127,544
Heather Corn, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $10,425
Endocrinology, Diabetes & Metabolism $10,425
Jamie Brewer, Np, NP
Endocrinology, Diabetes & Metabolism — Payments: $6,298
Endocrinology, Diabetes & Metabolism $6,298
Meenakshi Pande, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $6,081
Endocrinology, Diabetes & Metabolism $6,081